dm+d

371296007

Articles

Safety in Lactation: Anti-infective eye preparations

30 October 2020Anti-infective preparations for ophthalmic use have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. Systemic absorption from eye drops…

Safety in Lactation: Quinolones

21 October 2020Quinolones are generally accepted for use during breastfeeding, with caution. There have been concerns about adverse effects on infants’ developing joints, although this has only…
Search Articles

Medicine Compliance Aid Stability

AveloxBayer plc

Bayer plc
Avelox
Tablets 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from moisture. Protect from light. Maximum 7 days in MCA.
19 June 2015

genericActavis UK Ltd

Actavis UK Ltd
generic
Tablets 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Hygroscopic Protect from moisture. Protect from light. Maximum 7 days in MCA.
15 June 2015

Lactation Safety Information

Oral / Intravenous

Oral / Intravenous
Ciprofloxacin
No published evidence of safety
Likely to pass into breast milk but quantity unknown
4 August 2020

For ophthalmic use

For ophthalmic use
Yes
4 August 2020